Loxo Oncology, Inc. Stock Split Ratio
Loxo Oncology, Inc. reported Stock Split Ratio of 156.25% for the 1-month period ending 2014-07-31, per its 10-K filed 2015-03-27.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2015-03-27
- 2014-07-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 156.25%.
- 2013-07-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 207.00%.
- 2013-07-03: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 48.31%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2014-07-31 | 156.25% 10-K · filed 2015-03-27 | |
| 2013-07-31 | 207.00% 10-K · filed 2015-03-27 | |
| 2013-07-03 | 48.31% 10-Q · filed 2014-11-14 |